Diabetic Ketoacidosis clinical trials
The registry lists 76 studies for Diabetic Ketoacidosis across more than 10 countries. 17 are recruiting or about to start. 50 of them are mainly about Diabetic Ketoacidosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.
Get an email when these change. Save the Diabetic Ketoacidosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Assiut University (4) · Emory University (4) · Sohag University (3) · HealthPartners Institute (2) · University of California, Davis (2) · The Cleveland Clinic (2) · Indigo Diabetes NV (2) · University of Colorado, Denver (2)
What is being tested here
Drugs under test in Diabetic Ketoacidosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 7
- Jan 2027Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity · Emory University
- Mar 2027Perfusion Index for Predicting Diabetic Ketoacidosis Severity in the Emergency Department · Ankara Etlik City Hospital
- Jun 2027The BRIGHT Study (Device Name: HALO System) · Indigo Diabetes NV
- Jun 2027Postoperative Euglycemic Ketoacidosis Frequency in Sodium-Glucose Cotransporter-2 Inhibitor Users · Kocaeli City Hospital
- Sep 2027Leukocyte Glucose Index and Severity of Diabetic Ketoacidosis · Assiut University
- Oct 2027Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes · David K Carroll
- Nov 2027Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes · Paulex Bio Inc.
Who these studies take
Of the 11 Diabetic Ketoacidosis studies recruiting now, 5 (45%) set no upper age limit and 6 (55%) stop at 75 or younger. 3 (27%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (27%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (27%) | 3 (27%) |
| 18 | 8 (73%) | 8 (73%) |
| 30 | 8 (73%) | 8 (73%) |
| 40 | 8 (73%) | 8 (73%) |
| 50 | 8 (73%) | 8 (73%) |
| 65 | 8 (73%) | 8 (73%) |
| 75 | 7 (64%) | 7 (64%) |
| 85 | 5 (45%) | 5 (45%) |
Across all 76 studies, recruiting or not: 51% stop at 75 or younger and 43% at 65; 37% take children; 0% are for women only and 3% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Diabetic Ketoacidosis studies take
Of 16 interventional studies with no phase under Diabetic Ketoacidosis, half reached primary completion within 13 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 13 mo9–15 · 16 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 15, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 76. Browse all 76 → or search them.
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 DiabetesNot yet recruitingNCT07901595Phase 1/2
- Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.Not yet recruitingNCT07325201Phase 21 country
- Leukocyte Glucose Index and Severity of Diabetic KetoacidosisNot yet recruitingNCT07821814
- Perfusion Index for Predicting Diabetic Ketoacidosis Severity in the Emergency DepartmentRecruitingNCT078203711 country
- The BRIGHT Study (Device Name: HALO System)Not yet recruitingNCT07745998Not applicable
- Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of GlucotoxicityRecruitingNCT06699810Phase 41 country
- Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 DiabetesRecruitingNCT06236607Not applicable1 country
- Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 DiabetesRecruitingNCT074838791 country
- General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care DeliveryRecruitingNCT044779281 country
- Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 DiabetesRecruitingNCT07167693Phase 1/21 country
- Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin PoisoningRecruitingNCT071930691 country
- REAMBERIN® 1.5% in Rehydration Therapy of Diabetic KetoacidosisRecruitingNCT06955416Phase 2/31 country
- Serum Ferritin and Prognosis of DKARecruitingNCT067483651 country
- Children with Diabetic KetoacidosisNot yet recruitingNCT06599203
- Electrolyte Balance Effects of Sterofundin Versus Normal Saline in Diabetic KetoacidosisRecruitingNCT06399510Not applicable1 country
- EtCO2 for Monitoring and Predicting Severity of DKA in Pediatric Emergency, Doha, Qatar.RecruitingNCT041215721 country
- Risk Factors and Outcomes of Acute Kidney Injury in Patients With Diabetic Ketoacidosis at Sohag University Hospital.Not yet recruitingNCT05867797
- Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosisCompletedNCT05752279Phase 31 country
- Starvation in the Treatment of Diabetic KetoacidosisCompletedNCT06186245Not applicable1 country
- Thiamine as Adjunctive Therapy for Diabetic KetoacidosisCompletedNCT03717896Phase 21 country
- Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis.CompletedNCT07467616Not applicable1 country
- Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic KetoacidosisWithdrawnNCT06693115Not applicable1 country
- Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin PatientsCompletedNCT07423559Not applicable1 country
- A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 DiabetesTerminatedNCT06471322Not applicable1 country
- Hemoglobin Levels and Resolution Time of Diabetic Ketoacidosis in Pediatric PatientsActive, not recruitingNCT073776041 country
- Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate RiskCompletedNCT054025791 country
- Postoperative Euglycemic Ketoacidosis Frequency in Sodium-Glucose Cotransporter-2 Inhibitor UsersActive, not recruitingNCT071274061 country
- Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic ComplicationsCompletedNCT05443802Not applicable1 country
- Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)CompletedNCT05439928Not applicable1 country
- Intravenous Fluids in Adults With Diabetic Ketoacidosis in the Emergency DepartmentCompletedNCT04926740Not applicable1 country
- Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)TerminatedNCT04234867Phase 11 country
- Inferior Vena Cava Collapsibility and Distensibility Assessment in Critical Care.CompletedNCT06516692Not applicable1 country
- Two Bag System for Diabetic KetoacidosisTerminatedNCT03660189Not applicable1 country
- Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients with Type 2 DiabetesCompletedNCT040172211 country
- Double Blinded Randomized Control Trial of Types of IVF in Children With DKATerminatedNCT03066440Phase 41 country
- 0.9% Saline Versus Balanced Solutions in Severe Diabetic KetoacidosisCompletedNCT05808972Phase 41 country
- Diabetic Ketoacidosis Diagnosis and ManagementCompletedNCT063277371 country
- The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic SubjectsCompletedNCT05597605Not applicable3 countries
- Compliance With American Diabetes Association Treatment Guidelines for Adult KetoacidosisCompletedNCT005896801 country
- Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 DiabetesCompletedNCT02777073Not applicable1 country
- Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes MellitusCompletedNCT062518951 country
- Exogenous Ketones in People With Type 1 DiabetesWithdrawnNCT04487678Not applicable
- Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'CompletedNCT052254671 country
- Clinical and Laboratory Parameters Associated With Different Degrees of Dehydration Among Children With Diabetic KetoacidosisStatus unknownNCT053834041 country
- Use of Blood Ketone Meters to Improve Ambulance Hyperglycaemia CareCompletedNCT04940897Not applicable1 country
- Role of CBC as a Prognostic Marker for DKA PatientsStatus unknownNCT056668951 country
- Checklists Resuscitation Emergency DepartmentStatus unknownNCT05649891Not applicable
- StatStrip Glucose/Ketone Meter System Ketone EvaluationCompletedNCT051180612 countries
- Early Basal Insulin Administration in Adult Diabetic Ketoacidosis ManagementTerminatedNCT04567225Phase 41 country
- Prevalence of Acute Kidney Injury in Patients With Diabetic KetoacidosisStatus unknownNCT05508490